- Glaxo unveils pact to develop DNA vaccines
Submitted by ipsita on Fri, 1998-03-06 10:30
Glaxo Wellcome PLC continued its cautious march back into the vaccine business by unveiling a DNA vaccine collaboration with Powderject Pharmaceuticals PLC, a fledgling Oxford, England land based
Main Topic:
Mark Content Private(Internal):
Clipping Type:
DNB
External URL:
Main Type:
dte-DNB
Publication Date:
06/03/1998